Pramodini Medicare IPO Listing gains
| IPO Listing Date | August 19, 2026 |
| NSE Code | PRAMODINI |
| ISIN Code | INE2JG601017 |
| Offer Price | ₹110 to ₹118 |
| Face Value | ₹10 |
| Listing Price | ₹120 |
Details About Pramodini Medicare IPO
Pramodini Medicare received SEBI approval for an IPO of around ₹69.04 crores. The fresh issue was ₹63.14 crores and offer for sale up to 5,00,400 equity shares with face value of ₹10 each. Further, Pramodini Medicare had a price band of ₹110 to ₹118 per share.
In the Pramodini Medicare IPO, 2400 shares were offered in 2 lot sizes for the retail minimum and maximum categories. 3600 shares were offered in 3 lot sizes in the S-HNI category. 8,400 shares were in 7 lot sizes for the S-HNI Maximum category. B-HNI Minimum has around 9,600 shares in 8 lot sizes.
To invest in the Pramodini Medicare IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum and maximum investment of ₹2,83,200.
- S-HNI (Min): Minimum investment of ₹4,24,800.
- S-HNI (Max): Maximum investment of ₹9,91,200.
- B-HNI (Min): Minimum investment of ₹11,32,800.
Pramodini Medicare IPO’s Subscription Duration
The opening date of the Pramodini Medicare IPO was August 12, 2026, and the closing date was August 14, 2026. The allotment date of the Pramodini Medicare IPO was August 17, 2026, and the investors will receive a refund on August 18, 2026. Pramodini Medicare is set to be listed on August 19, 2026.
Funds Deployment of This Company
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres.
- General corporate purposes and unidentified inorganic acquisition
- Lastly, some funds will go to the General Corporate Purpose
About Pramodini Medicare Company
Pramodini Medicare Limited, founded in 2000, is one of the leading diagnostic services providers in India across radiology, clinical laboratory, and nuclear medicine segments. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.
Pramodini Medicare operates diagnostic centres through Public-Private Partnerships (PPP), Private-Private Partnerships (Pvt-Pvt), Strategic Partnerships with PSUs, Standalone Diagnostic Centres, and Location-Specific Agreements.